U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07412444) titled 'EVOO and Metabolic Liver Health in MASLD' on Jan. 16.
Brief Summary: MASLD is currently one of the most common chronic non-communicable diseases and the leading cause of liver-related mortality and morbidity, with a rising prevalence worldwide, especially in the presence of obesity, diabetes, and other cardio-metabolic risk factors. Lifestyle modification, particularly through the Mediterranean Diet, is the first-line intervention, and extra virgin olive oil is a key component thanks to its monounsaturated fatty acids and bioactive compounds with anti-inflammatory and antioxidant effects.
Several studies indicate that extra virgin ...